You are here

Article info

Article menu

Download PDFPDF

Review
A New VISTA on combination therapy for negative checkpoint regulator blockade

Authors

  • Jie Deng Department of Microbiology and ImmunologyGeisel School of Medicine at Dartmouth, Norris Cotton Cancer Center One Medical Center Drive, Room 730 03756 Lebanon NH USA PubMed articlesGoogle scholar articles
  • Isabelle Le Mercier Department of Microbiology and ImmunologyGeisel School of Medicine at Dartmouth, Norris Cotton Cancer Center One Medical Center Drive, Room 730 03756 Lebanon NH USA ImmuNext, Inc. One Medical Center Drive 03756 Lebanon NH USA PubMed articlesGoogle scholar articles
  • Anna Kuta Department of Microbiology and ImmunologyGeisel School of Medicine at Dartmouth, Norris Cotton Cancer Center One Medical Center Drive, Room 730 03756 Lebanon NH USA PubMed articlesGoogle scholar articles
  • Randolph J. Noelle Department of Microbiology and ImmunologyGeisel School of Medicine at Dartmouth, Norris Cotton Cancer Center One Medical Center Drive, Room 730 03756 Lebanon NH USA ImmuNext, Inc. One Medical Center Drive 03756 Lebanon NH USA PubMed articlesGoogle scholar articles
  1. ↵a Jie.Deng{at}dartmouth.edu
  2. ↵b lemercier{at}immunext.com
  3. ↵c Anna.Kuta{at}dartmouth.edu
  4. ↵d Randolph.J.Noelle{at}dartmouth.edu
View Full Text

Citation

Deng J, Le Mercier I, Kuta A, et al
A New VISTA on combination therapy for negative checkpoint regulator blockade
Journal for ImmunoTherapy of Cancer 2016;4:86. doi: 10.1186/s40425-016-0190-5

Publication history

  • Received July 12, 2016
  • Accepted November 7, 2016
  • First published December 20, 2016.
Online issue publication 
December 20, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.